Several reports demonstrated the important role of Sig-1R in non-neuronal cells, since in different neurodegenerative disorders the resulting glial activation was modified after treatment with a Sig-1R ligand, such as in stroke [48], pain [49] and MN diseases [24,25,44,50]. The gene discussed is SIGMAR1; the disease is Stroke.